| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 06/05/2002 | EP1109817B1 Phosphohalohydrins, method for making same and uses |
| 06/05/2002 | EP0925308B1 Compositions and methods for treating infections using analogues of indolicidin |
| 06/05/2002 | EP0755386B1 Benzamide derivative, compositions containing said derivative and use thereof |
| 06/05/2002 | CN1352645A 4-substituted milbemycin derivatives |
| 06/05/2002 | CN1352559A Endoparasiticidal combination |
| 06/05/2002 | CN1352554A IL-8 receptor antagaonists |
| 06/04/2002 | US6399786 Nonacyclic nodulisporic acid derivatives |
| 06/04/2002 | US6399643 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom |
| 06/03/2002 | WO2002000202A1 Endoparasiticidal agents for voluntary oral ingestion by animals |
| 05/30/2002 | WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002041886A1 Ydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections |
| 05/30/2002 | WO2002022599A3 Chemokine receptor binding heterocyclic compounds |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 05/30/2002 | WO2001040223B1 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | WO2000024411A3 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| 05/30/2002 | US20020065391 Compound for use in the treatment of arthritis, inflammatory bowel disease, nervous system and cardiovascular disorders, arteriosclerosis, restenoses, diabetes, grafted organ damage, asthma, allergies, tumor metastasis and malaria |
| 05/30/2002 | US20020065302 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/30/2002 | US20020065296 Administering heteroarylurea compound for therapy of cytokine mediated diseases and proteolytic enzyme mediated diseases |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065235 Ketolide antibiotics |
| 05/30/2002 | US20020064830 Nucleotide sequences for use as diagnostic tools |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |
| 05/30/2002 | EP1143986A3 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds |
| 05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/29/2002 | EP1208751A1 Natural physiologically active substances efficacious against fish parasites and fish feeds containing the substances |
| 05/29/2002 | EP1208199A2 DNA CODING FOR $g(b)-TUBULIN AND USE THEREOF |
| 05/29/2002 | EP1208100A1 Selective antagonists of a2b adenosine receptors |
| 05/29/2002 | EP1207908A1 Method of treating body insect infestation |
| 05/29/2002 | EP1207851A1 Topical organic ectoparasiticidal formulations |
| 05/29/2002 | EP1207757A1 Ectoparasiticidal aqueous suspension formulations of spinosyns |
| 05/29/2002 | EP1207756A1 Oral treatment of companion animals with ectoparasiticidal spinosyns |
| 05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
| 05/29/2002 | CN1351608A B-methyl-erythromycin derivatives |
| 05/29/2002 | CN1351607A Novel crystalline forms of macrolide antibiotic |
| 05/29/2002 | CN1351599A Indole-type derivatives as inhibitors of P38 kinase |
| 05/29/2002 | CN1351488A Drinkable pharmaceutical solution |
| 05/29/2002 | CN1351468A (s)-Enantiomer enriched tipronil composition |
| 05/29/2002 | CN1085527C Preparation method of synergistic antimalarial compound benzfluorenol |
| 05/28/2002 | US6395777 Ionic polymers as anti-infective agents |
| 05/28/2002 | US6395765 Parasiticides |
| 05/28/2002 | US6395754 Antiinflammatory agents, cardiovascular disorders, antipyretics |
| 05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
| 05/23/2002 | WO2002040518A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002040499A1 A method for generating genetically altered antigens |
| 05/23/2002 | WO2002040462A2 Cysteine protease inhibitors |
| 05/23/2002 | WO2002040058A2 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers |
| 05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | WO2002002115A3 Anthelminthic agents for the prevention of parasitic infections in humans and animals |
| 05/23/2002 | WO2001083774A3 Novel mutated form of arginine deiminase |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001001975A3 Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents |
| 05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
| 05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
| 05/23/2002 | US20020061898 Inhibitors of nucleoside metabolism |
| 05/23/2002 | US20020061858 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives |
| 05/23/2002 | US20020061314 Administering to animal live vaccine containing organisms to develop immunological response, maintaining animal free from drugs effective against infectious organism for period of one life or infectious cycle of organism, administering drug |
| 05/23/2002 | US20020061310 Compositions and methods for dendritic cell-based immunotherapy |
| 05/23/2002 | US20020060381 Method of producing a compensator for radiotherapy equipment and an apparatus for producing the same |
| 05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2429144A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 05/23/2002 | CA2428863A1 Cysteine protease inhibitors |
| 05/22/2002 | EP1206477A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206279A1 Method for treating tnf-receptor type-2-induced diseases |
| 05/22/2002 | EP1206258A1 Compositions containig esthers for treating parasitic infestations of organisms |
| 05/22/2002 | CN1350592A Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 05/22/2002 | CN1350458A Protease inhibitors |
| 05/21/2002 | US6392026 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 05/16/2002 | WO2002038753A1 Method of screening gene affecting pathological conditions or survival of animal infected with pathogen |
| 05/16/2002 | WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | WO2002038534A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/16/2002 | WO2002038176A2 Immunogenic compositions comprising liver stage malarial antigens |
| 05/16/2002 | WO2002038173A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 05/16/2002 | WO2002038127A2 Particle formation methods and their products |
| 05/16/2002 | WO2001098364A3 Peptides, compositions and methods for the treatment of burkholderia cepacia |
| 05/16/2002 | WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | US20020058683 Oral combination of lufenuron and nitenpyram against fleas |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058321 Method of determining the activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5-phosphate synthase |
| 05/16/2002 | US20020058288 Compound for use in the detection and prevention of parasitic infection of humans |
| 05/16/2002 | US20020058047 Vaccines |
| 05/16/2002 | CA2428453A1 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | CA2428266A1 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
| 05/16/2002 | CA2428117A1 Immunogenic compositions comprising liver stage malarial antigens |
| 05/15/2002 | EP1205183A2 Antimicrobial composition containing cellulose acetate |
| 05/15/2002 | EP1204756A2 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 05/15/2002 | EP1204422A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 05/15/2002 | EP1204420A2 Trehalose producing prokaryotic cells as vaccines |
| 05/15/2002 | EP1204416A1 Carnitine analogues as topical, microbicidal spermicides |
| 05/15/2002 | EP1204411A1 Apicidin-derived cyclic tetrapeptides |